Reliance Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 126.01 Cr
- Paid Up Capital ₹ 96.01 Cr
- Company Age 24 Year,
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1,366.61 Cr
- Satisfied Charges ₹ 172.84 Cr
- Revenue Growth 47.54%
- Profit Growth 290.04%
- Ebitda 133.57%
- Net Worth 90.52%
- Total Assets 46.93%
About Reliance Life Sciences
Reliance Life Sciences Private Limited (RLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 January 2001 and has a history of 24 years. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 126.01 Cr and a paid-up capital of Rs 96.01 Cr.
The company currently has active open charges totaling ₹1,366.61 Cr. The company has closed loans amounting to ₹172.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Reliance Life Sciences Private Limited India is Hardeep Sodhi as COMPANY SECRETARY. Laxmidas Merchant, Venkata Ramana, Shailaja Saxena, and Two other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24239MH2001PTC130654
- Company No.
130654
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2001
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Reliance Life Sciences Private Limited offer?
Reliance Life Sciences Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Immunomodulator Drugs, Anti Cancer Medicines, Human Albumin Injection, Immunization & Vaccination Drugs, Rabies Vaccine, Capecitabine Tablets, Normal Immunoglobulin, TB, Tumor & Cancer Drugs, Cisplatin Injection Bp.
Who are the key members and board of directors at Reliance Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hardeep Sodhi  | Company Secretary | 08-Sep-2014 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Laxmidas Merchant | Director | 01-Jun-2007 | Current |
| Venkata Ramana | Whole-Time Director | 10-Jan-2022 | Current |
| Shailaja Saxena | Whole-Time Director | 30-Sep-2022 | Current |
| Ramaprasad Jayaraman | Whole-Time Director | 01-Jul-2016 | Current |
| Vinay Ranade | Whole-Time Director | 01-Jul-2016 | Current |
Financial Performance of Reliance Life Sciences.
Reliance Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.54% increase. The company also saw a substantial improvement in profitability, with a 290.04% increase in profit. The company's net worth Soared by an impressive increase of 90.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reliance Life Sciences?
In 2021, Reliance Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Balkrishna Industries LimitedLaxmidas Merchant is a mutual person
Oriental Rubber Industries Private LimitedLaxmidas Merchant is a mutual person
Kamalakar Enterprises LlpLaxmidas Merchant is a mutual person
- Narahari Enterprises Llp
Laxmidas Merchant is a mutual person
- Pranatharthi Commercials Private Limited
Laxmidas Merchant is a mutual person
- Rb Holdings Private Limited
Laxmidas Merchant is a mutual person
Charges (Loans)
₹1,366.61 Cr
₹172.84 Cr
Charges Breakdown by Lending Institutions
- Others : 1000.00 Cr
- Hdfc Bank Limited : 350.00 Cr
- State Bank Of India : 11.01 Cr
- Canara Bank : 5.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2024 | State Bank Of India | ₹0.10 M | Open |
| 22 Feb 2024 | Others | ₹1,000.00 Cr | Open |
| 04 Jan 2024 | Canara Bank | ₹5.60 Cr | Open |
| 28 Dec 2023 | State Bank Of India | ₹11.00 Cr | Open |
| 23 Aug 2022 | Hdfc Bank Limited | ₹350.00 Cr | Open |
How Many Employees Work at Reliance Life Sciences?
Reliance Life Sciences has a workforce of 1457 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reliance Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reliance Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
